NCT05579548
Phenylketonuria, Phenylketonuria, Maternal
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
This is a Phase 4 observational study designed to assess the impact of Palynziq ® (pegvaliase) treatment in pregnant women with PKU and on their offspring who were exposed to pegvaliase at any time during pregnancy and breastfeeding.
Female
Any
No
Pegvaliase
Observational
50
2022-11-22
2025-11-28
Wilmington, North Carolina, United States
Trial Status Recruiting
Coordinating Center
833-672-2203 PalynziqPregnancyStudy@syneoshealth.com
Calgary, Canada
Trial Status Recruiting
Aneal Khan, Dr
587-885-3158 aneal.khan@discoverydna.ca
Hamburg, Germany
Trial Status Recruiting
Professor Muntau
muntau@uke.de
Milan, Italy
Trial Status Recruiting
Dr. Rovelli
valentina.rovelli@asst-santipaolocarlo.it
• Currently participating in a BioMarin sponsored interventional study of any investigational product, device, or procedure
*required fields
"*" indicates required fields